Navigation Links
Certain cancers more common among HIV patients than non-HIV patients
Date:9/25/2009

DALLAS Sept. 25, 2009 Researchers at UT Southwestern Medical Center have found that non-AIDS-defining malignancies such as anal and lung cancer have become more prevalent among HIV-infected patients than non-HIV patients since the introduction of anti-retroviral therapies in the mid-1990s.

AIDS patients with suppressed immune systems are at higher risk for so-called AIDS-defining malignancies cancers such as non-Hodgkin's lymphoma, Kaposi's sarcoma and cervical carcinoma. Some researchers have speculated, however, that HIV patients are diagnosed with more non-AIDS-defining malignancies simply because anti-retroviral drugs now used enable them to live longer, but the results of the UT Southwestern study suggest that other factors may be at work.

The researchers, using data from more than 100,000 patient records in the U.S. Veterans Affairs Healthcare System, found that when the statistics were adjusted for gender, race/ethnicity and age, HIV-infected patients were 60 percent more likely to have anal, lung, Hodgkin's, melanoma or liver cancer than patients without HIV. The rate of prostate cancer was similar between the two groups, according to the report.

"It's a genuine increase in the incidence of these cancers," said Dr. Roger Bedimo, assistant professor of internal medicine at UT Southwestern and lead author of a study appearing online and in the October edition of the Journal of Acquired Immune Deficiency Syndromes. "The increase is more visible because these patients are living longer, but our findings suggest that the increased number of non-AIDS-defining malignancies is not simply the result of their longer lives."

For the study, researchers compared the rates of non-AIDS-defining malignancies between patients with and without HIV who received care at a VA system facility between 1997 and 2004. For each HIV-positive patient, researchers identified at least two HIV-negative patients who received care the same year and matched them on age, sex, race and geographic location. The final study population included 33,420 HIV-infected patients and 66,840 non-infected patients.

The non-AIDS-defining malignancies included all forms of cancer except skin, lymphoma, cervical carcinoma, Kaposi's sarcoma and ill-defined cancers. Dr. Bedimo said the researchers examined anal, lung, melanoma, prostate, Hodgkin's and liver cancers all non-AIDS-defining individually.

Dr. Bedimo, chief of infectious disease at the Veterans Affairs North Texas Health Care System, said it's unclear exactly why non-AIDS-defining malignancies are more common in HIV patients than the general population. One controversial theory, he said, is that the anti-retroviral therapy itself might increase the risk of those cancers in HIV patients.

"The second hypothesis is that HIV-infected patients somehow, either by their lifestyle or other circumstances, are more subject to the traditional risk factors than non-HIV patients," he said. "The third hypothesis is that HIV or another undetected virus increases a patient's risk for developing cancer intrinsically."

Dr. Bedimo said that one major limitation of the study is the overrepresentation of males in the study. Males account for about 98 percent of the study population.

The next step is for researchers to examine other measures of immune function in patients with and without cancer.

"The hallmark of chronic HIV is a decline in CD4 T-cells, but we also know that HIV does a lot more to your immune system than just decrease the number of these cells," Dr. Bedimo said. "It's very possible that it is an immune dysfunction that impairs the cancer immune surveillance in patients even after their CD4 counts have increased."


'/>"/>

Contact: Kristen Holland Shear
Kristen.hollandshear@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
Source:Eurekalert  

Related medicine news :

1. H1N1 Swine Flu Preparedness Uncertainty Results in Higher Business Disruption Risk
2. Trauma 411: Prolonged surgery should be avoided in certain cases
3. Pain Level May Predict Survival in Certain Cancer Patients
4. Bayer Statement on U.S. Food and Drug Administration Advice for Patients: Serious Errors with Certain Blood Glucose Monitoring Test Strips
5. Taking dex can improve high altitude exercise capacity in certain climbers
6. Certain Arthritis, Crohns Drugs May Raise Kids Cancer Risk: FDA
7. Sun exposure may trigger certain autoimmune diseases in women
8. Concierge Medicine Takes Front Seat with Health Care Reform Uncertainty
9. Quest Diagnostics Announces Pricing of Tender Offer for Up to $200 Million Aggregate Principal Amount of Certain of its Outstanding Notes
10. Quest Diagnostics Announces Early Tender Results of Offer to Purchase Up to $200 Million Aggregate Principal Amount of Certain of its Outstanding Notes
11. The Quigley Corporation Announces Final Voting Results for 2009 Annual Meeting of Shareholders; Judge Orders Incumbent Board to Remain In Place Until Further Hearing; Final Outcome of Director Election Remains Uncertain
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Certain cancers more common among HIV patients than non-HIV patients
(Date:1/15/2017)... ... , ... Whole Health Supply, LLC is announcing the release of an updated version of their ... , The 2017 edition has wide jaws that will accommodate nails up to 4mm ... as diabetics. This handle is reinforced for extra strength when pressing down on dense nails ...
(Date:1/15/2017)... (PRWEB) , ... January 15, 2017 , ... The Gravity ... location in Radnor, Pennsylvania. As construction wraps up on the 14,000+ square foot climbing ... Gravity Vaults sixth location, including three in New Jersey and two in New York. ...
(Date:1/14/2017)... ... January 14, 2017 , ... "TransFreeze Volume 3 is a self animating masking transition which ... Final Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. , ... frame transition from one clip to the next. , To use “Cut-Out First” ...
(Date:1/13/2017)... ... 2017 , ... With the increasing public preference for chemical-free ... organic alternatives for customers who have grown more conscious about maintaining their health ... activated charcoal products, Moody Zook Chief Executive Officer Nate Ginsburg explained their company’s ...
(Date:1/13/2017)... , ... January 13, 2017 , ... Friday, January 13 ... of the game room, increasing the size of the location to 90,000 square feet. ... 8-hole mini golf course that takes customers on an educational tour of the historic ...
Breaking Medicine News(10 mins):
(Date:1/13/2017)... Research and Markets has announced the addition of the ... their offering. ... Cystic fibrosis (CF) is a progressive genetic condition and is the ... regulator (CFTR) gene from both parents. The defective CFTR genes produce ... the buildup of a thick and sticky mucus in the lungs ...
(Date:1/13/2017)... , Jan. 12, 2017  Albertsons Companies proudly ... Commission for Health Care (ACHC) for its specialty ... food and drug chain with this accreditation and ... patients. Accreditation by ACHC reflects Albertsons ... to facilitate a higher level of performance and ...
(Date:1/13/2017)... , Jan. 13, 2017  Biologics Prescribers ... Drug Administration (FDA) for issuing final guidance ... medicines. This policy is an important win ... is essential for pharmacovigilance, patient safety and ... has voiced to FDA, we remain concerned with "random" ...
Breaking Medicine Technology: